Impact of proton pump inhibitors on clinical outcomes in patients after acute myocardial infarction: a propensity score analysis from China Acute Myocardial Infarction (CAMI) registry

BACKGROUND: Proton pump inhibitors (PPIs) are recommended by the latest guidelines to reduce the risk of bleeding in acute myocardial infarction (AMI) patients treated with dual antiplatelet therapy (DAPT). However, previous pharmacodynamic and clinical studies have reported controversial results on...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Geriatr Cardiol
Main Authors: SHI, Wen-Ce, GAO, Si-De, YANG, Jin-Gang, FAN, Xiao-Xue, NI, Lin, SU, Shu-Hong, YU, Mei, YANG, Hong-Mei, YU, Meng-Yue, YANG, Yue-Jin, on behalf of China Acute Myocardial In-farction (CAMI) Registry study group
Formato: Artigo
Idioma:Inglês
Publicado: Science Press 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7729183/
https://ncbi.nlm.nih.gov/pubmed/33343644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11909/j.issn.1671-5411.2020.11.008
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares